help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, T. J.
Right arrow Articles by Drummond, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, T. J.
Right arrow Articles by Drummond, G. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LEVOTHYROXINE
*LIOTHYRONINE

Endocrinology, Vol 122, 1964-1967, Copyright © 1988 by Endocrine Society


ARTICLES

Thyroid hormone regulation of heme synthesis in rat liver

TJ Smith and GS Drummond
Department of Medicine, State University of New York at Buffalo.

Thyroid hormone alters the rate of heme degradation and the levels of cytochrome P450 in rat liver. These studies report the effects of thyroid status on the activity of hepatic delta-aminolevulinate synthase (ALAS), the initial and rate-limiting enzyme in heme synthesis. Thyroidectomized male Sprague-Dawley rats received sc injections of diluent or hormones. T3 was found to stimulate ALAS activity in the liver in doses which rendered the animals euthyroid (0.3 microgram/100 g BW.day). Higher doses failed to enhance enzyme activity further. T4 had similar effects but was less potent; rT3 had no effect on ALAS activity. The administration of a large single dose of T3 (50 micrograms/100 g BW) produced a significant (P less than 0.001) increase in ALAS activity 72 h later. Allylisopropylacetamide administration induced ALAS activity to identical levels in both hypothyroid and T3-replaced animals when administered at a dose of 200 mg/kg body wt. A dose of 400 mg/kg body wt allylisopropylacetamide, one associated with maximal induction of ALAS, resulted in an 80% higher enzyme activity in T3-treated animals compared with controls. Exogenous T3 had no effect on ALAS activity in sham-operated animals. These findings indicate that thyroid status can influence the activity of ALAS, the rate-limiting enzyme in the synthesis of heme in rat liver, as well as heme degradation and the content of cytochrome P450 in this organ.


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. G. Abraham and A. Kappas
Pharmacological and Clinical Aspects of Heme Oxygenase
Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
F. S. Gravina, C. K. B. da Silveira, A. M. de Assis, D. K. Rieger, C. Guerini, A. P. Muller, M. Farina, L. N. Rotta, and M. L. S. Perry
Experimental Hypothyroidism Inhibits {delta}-Aminolevulinate Dehydratase Activity in Neonatal Rat Blood and Liver
Experimental Biology and Medicine, September 1, 2007; 232(8): 1021 - 1026.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society